Table 1 Patients' baseline characteristics

Mean Age (yrs)

34 ± 12

M/F

36/25

Disease Duration (months)

47 ± 7

% disease beyond splenic flexure

63

% Previous ASA use

96

% Previous AZA use

11

% Previous steroid use

100